Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Imatinib mesylate associated with delayed hematopoietic recovery after concomitant chemotherapy

Leukemia volume 18, pages 886–887 (2004)Cite this article

TO THE EDITOR

We read with interest the paper by Ruchatz et al1 on the effect of imatinib on hematopoietic recovery following idarubicin exposure in murine model. We describe an elderly patient with chronic myeloid leukemia (CML) and transformed large B-cell lymphoma treated with imatinib mesylate and combination chemotherapy.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Ruchatz H, Puttini M, Cleris L, Pilotti S, Gambacorti-Passerini C, Formelli F . Effect of imatinib on haematopoietic recovery following idarubicin exposure. Leukemia 2003; 17: 298–304.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section on Hematology and Oncology, Comprehensive Cancer Center at Wake Forest University, Winston-Salem, NC, USA

    M Chand, M Thakuri & Y-K Keung

Authors
  1. M Chand
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Thakuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y-K Keung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y-K Keung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chand, M., Thakuri, M. & Keung, YK. Imatinib mesylate associated with delayed hematopoietic recovery after concomitant chemotherapy. Leukemia 18, 886–887 (2004). https://doi.org/10.1038/sj.leu.2403311

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403311

This article is cited by

Search

Advanced search

Quick links